Recent advances in nephrology.
The World Congress of Nephrology was held in Berlin, Germany, June 8-12, 2003. The meeting offered the newest advances in basic and clinical nephrology science and was attended by about 9,000 scientists and clinicians from around the world. During the congress, results of the treatment of Fabry's disease with enzyme replacement therapy, the results of the treatment of anemia in patients with chronic kidney disease with new erythropoietic agents (darbepoetin alfa, continuous erythropoiesis receptor activator), and the management of secondary hyperparathyroidism and calcium-phosphorus disorders in uremia with calcimimetic agents and new phosphate binders, such as lanthanum carbonate, were discussed. Furthermore, recent studies evaluating the efficacy and safety of new immunosuppressive agents and their combination for the treatment of renal transplant recipients were also presented.
Cases
Aleix
A
Dialysis Section, Nephrology Department, Hospital Clinic i Provincial, University of Barcelona, Barcelona, Spain. acases@medicina.ub.es
D000740:Anemia / Q000150:complications / Q000188:drug therapy; D017610:Calcium Compounds / Q000627:therapeutic use; D000795:Fabry Disease / Q000150:complications / Q000188:drug therapy / Q000235:genetics; D030342:Genetic Diseases, Inborn / Q000150:complications / Q000188:drug therapy; D006084:Graft Rejection / Q000188:drug therapy / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D007674:Kidney Diseases / Q000150:complications / Q000188:drug therapy* / Q000235:genetics; D016030:Kidney Transplantation / Q000276:immunology; D009398:Nephrology / Q000639:trends*; D010710:Phosphates / Q000627:therapeutic use
D017610:Calcium Compounds; D010710:Phosphates